Number of shares of equity interests issued or issuable to acquire entity.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the additional shares issued or issuable for business acquisition.

+ References

No definition available.

+ Details

Name:	ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares
Namespace Prefix:	ycbd_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the expiration period for additional shares issuable.

+ References

No definition available.

+ Details

Name:	ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration
Namespace Prefix:	ycbd_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the vesting period of issued and/or issuable shares issued for acquisition.

+ References

No definition available.

+ Details

Name:	ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod
Namespace Prefix:	ycbd_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_BusinessAcquisitionAxis=ycbd_CureBasedDevelopmentLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=ycbd_RegisteredCommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=ycbd_UnregisteredCommonStock2Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=ycbd_UnregisteredCommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Note 6 - Contingent Consideration (Details Textual) - Cure Based Development, Llc [Member] - shares		1 Months Ended	9 Months Ended
	Dec. 20, 2018	Apr. 30, 2019	Jun. 30, 2022
Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)		338,889	271,405
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares)		338,889
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares, Expiration (Month)	60 months
Registered Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)		144,445
Unregistered Common Stock 2 [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)		194,945
Unregistered Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)		194,445
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)		5 years